NHS drugs go-ahead offers lifeline to children with rare muscle-wasting disease
Medicines watchdog approves two treatments for patients with spinal muscular atrophyHundreds of children with a rare muscle-wasting disease will be able to receive two drugs that can improve their survival in a move parents hailed as a “lifeline”.The National Institute for Health and Care Excellence (Nice) has published final draft guidance recommending that any patient who would benefit can have either drug. Continue reading...
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.